As frequencies of IL-17 expressing CD4+ and CD8+ T cells systemically increased after therapy in patients with vulvar or cervical cancer [16, 17], interaction of CTCs and IL-17 may favor CTC survival and their contribution to metastases. This evidence concerns the gene IL17A and cervical carcinoma.